A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa

Preventive Medicine

Volumn 39, Issue 5, 2004, Pages 1036-1046

  Guwatudde, D ^a   Debanne, S M ^b   Diaz, M ^b   King, C ^b   Whalen, C C ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deterministic model; HIV infection; Sub Saharan Africa; Tuberculosis control; Tuberculosis preventive therapy

Indexed keywords

AFRICA; ARTICLE; COMPARTMENT MODEL; DEATH; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MORTALITY; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; THEORETICAL MODEL; TUBERCULOSIS;

AFRICA SOUTH OF THE SAHARA; COMORBIDITY; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; PREVALENCE; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH; SURVIVAL RATE; TUBERCULOSIS;

EID: 4744344645     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.04.008     Document Type: Article

References (39)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 282(7):1999 (Aug);677-686
2. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2003. Geneva, Switzerland. WHO/CDS/TB/2003.316.
3. Dye C. Tuberculosis 2000-2010: control, but not elimination. Int. J. Tuberc. Lung Dis. 4(12 Suppl. 2):2000 (Dec);S146-S152
4. Harries A.D. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 335(8686):1990 (Feb 17);387-390
5. Raviglione M.C., Snider D.E., Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 273(3):1995 (Jan);220-226
6. Hawken M.P., Meme H.K., Elliott L.C., Chakaya J.M., Morris J.S., Githui W.A, et al. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS. 11(7):1997 (Jun);875-882
7. Pape J.W., Jean S.S., Ho J.L., Hafner A., Johnson W.D. Effect of Isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 342(8866):1993 (Jul);268-272
8. Whalen C.C., Johnson J.L., Okwera A., Hom D.L., Huebner R., Mugyenyi P., et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research collaboration. New Engl. J. Med. 337(12):1997 (Sep);801-808
9. WHO and IUATLD Tuberculosis preventive therapy in HIV infected individuals: a joint statement of the WHO Tuberculosis Programme and the Global Programme on AIDS, and the International Union Against Tuberculosis and Lund Disease (IUATLD). Wkly. Epidemiol. Rec. 68(49):1993 (Dec);361-364
10. WHO and UNAIDS. Policy statement on preventive therapy against tuberculosis in persons living with HIV. WHO/TB/98.255 or UNAIDS/98.34; 1998.
11. Borgdorff M.W., Floyd K., Broekmans J.F. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull. World Health Organ. 80(3):2002;217-227
12. Faussett G.P., Ayles H. The impact of HIV on tuberculosis control - Towards concerted action. Lepr. Rev. 73(4):2002 (Dec);376-385
13. Blower S.M., Daley C.L. Problems and solutions for the Stop TB partnership. Lancet Infect. Dis. 2(6):2002 (Jun);374-376
14. Bell J.C., Rose D.N., Sacks H.S. Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS. 13(12):1999 (Aug 20);1549-1556
15. Murray C.J., Salomon J.A. Modeling the impact of global tuberculosis control strategies. Proc. Natl. Acad. Sci. U. S. A. 95(23):1998 (Nov);13881-13886
16. Heymann S.J. Modeling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa. Trans. R. Soc. Trop. Med. Hyg. 87(4):1993 (Jul);406-411
17. Blower S.M., McLean A.R., Parco T.C., Small P.M., Hopewell P.C., Sancez M.A., et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat. Med. 1(8):1995 (Aug);815-821
18. World Health Organization Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995. Wkly. Epidemiol. Rec. 71(12):1996 (Mar 22);90-94
19. Anderson R., May R. Infectious diseases of humans: dynamics and control. 1991;Oxford Univ. Press, Oxford. Chaps. 1 and 2
20. Fitzgerald D.W., Desvarieux M., Severe P., Joseph P., Johnson W.D. Jr., Pape J.W. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomized trial. Lancet. 356(9240):2000 (Oct 28);1470-1474
21. Uganda Ministry of Health. Highlights of sector performance for financial year 2000-01. Brochure or website: www.health.go.ug. 2002 Jan.
22. Mbulaiteye S.M., Mahe C., Whitworth J.A.G., Ruberantwari A., Nakiyingi J.S., Ojwiya A., et al. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet. 360:2002 (Jul);41-46
23. Styblo K., Meijer J., Sutherland I. Tuberculosis surveillance unit, report no 1: the transmission of tubercle bacilli: its trend in a human population. Bull. Int. Union Tuberc. 42:1969 (Aug);1-104
24. Sutherland I., Svandova E., Radhakrishma S. Alternative models for development of tuberculosis disease following infection with tubercle bacilli. Bull. Int. Union Tuberc. 51(1):1976;171-179
25. Elliott A.M., Namaambo K., Allen B.W., Luo N., Hayes R.J., Pobee J.O.M., et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber. Lung Dis. 74(3):1993 (Jun);191-194
26. Palmieri F., Girardi E., Pellicelli A.M., Rianda A., Bordi E., Busi R.E., et al. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection. 30(2):2002;68-74
27. Bucher H.C., Griffith L.E., Guyatt G.H., Sudre P., Naef M., Sendi P., et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 13(4):1999 (Mar);501-507
28. Wilkinson D., Squire S.B., Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomized placebo controlled trials. BMJ. 317(7159):1998 (Sep);625-629
29. World Health Organization WHO tuberculosis programme: framework for effective tuberculosis control. 1994;WHO, Geneva. WHO/TB/94.179
30. Hawken M.P., Muhindi D.W. Tuberculosis preventive therapy in HIV-infected persons: feasibility issues in developing countries. Int. J. Tuberc. Lung Dis. 3(8):1999 (Aug);646-650
31. Holmes C.B., Losina E., Walensky R.P., Yazdanpanah Y., Freedberg K.A. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin. Infect. Dis. 36(5):2003 (Mar 1);652-662
32. Harries A.D., Hargreaves N.J., Chimzizi R., Salaniponi F.M. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bull. World Health Organ. 80(6):2002;464-469
33. Uganda Bureau of Statistics (UBOS) and ORC Macro Uganda demographic and health survey 2000-2001. 2001;UBOS and ORC Macro, Calverton, MD, USA
34. Nunn A.J., Mulder D.W., Kamali A., Ruberantwari A., Kengeya-Kayondo J.F., Whitworth J. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ. 315(7111):1997 (Sept);767-771
35. Uganda Ministry of Health Tuberculosis surveillance report. Qt. Bull. Integr. Dis. Surv. 1:2001 (Mar);19-21
36. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA. 271(9):1994 (Mar 2);698-702
37. Arbelaez M.P., Nelson K.E., Munoz A. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection. Int. J. Epidemiol. 29(6):2000 (Dec);1085-1091
38. Raviglione M.C., Harries A.D., Msiska R., Wilkinson D., Nunn P. Tuberculosis and HIV: current status in Africa. AIDS. 11(Suppl. B):1997;S115-S123
39. Elliott A.M., Halwiindi B., Hayes R.J., Luo N., Mwinga A.G., Tembo G., et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans. R. Soc. Trop. Med. Hyg. 89(1):1995 (Jan-Feb);78-82